Lower attention ability in adolescence can predict substance use in young adulthood

In trials, the product reduced itch and sleep disturbance within the first four weeks of treatment. Credit: Dermatology11/Shutterstock. The US Food and Drug Administration (FDA)

Out­look to con­duct an­oth­er tri­al for eye drug af­ter re­jec­tion: Out­look Ther­a­peu­tics an­nounced Thurs­day that the FDA wants an ad­di­tion­al study as­sess­ing be­va­cizum­ab in wet